The group’s principle activity is to provide genomic biotech services including gene assays to assist pharmaceutical and biotech companies with new drug development and multi-gene expression analysis. The group’s technology includes StaRT-PCR(TM). The group’s products include StaRT-PCR Biomarker Kits, and StaRT-PCR Assays. The group operates from United States.
